Visiopharm AI-driven Precision Pathology
Overview
Visiopharm AI-driven Precision Pathology is an image analysis software platform that utilizes artificial intelligence and deep learning for quantitative tissue analysis in both research and diagnostics. It is designed for pathologists, researchers, and image analysis experts.
- What it does: The platform provides tools for analyzing digital pathology images, enabling quantification of biomarkers, cell phenotypes, and spatial relationships within tissue. It includes modules for spatial biology analysis (Phenoplex™), general tissue image analysis (Discovery), and assessment of IHC staining consistency (Qualitopix).
- Who it is for: This tool is intended for pathologists in diagnostic settings, as well as scientists and researchers in academic institutions and the biopharmaceutical industry.
- How it fits a clinical or practice workflow: Visiopharm offers IVDR-certified CE-IVD APPs for diagnostic decision support, particularly for biomarker assessment in breast, lung, and prostate cancer. These applications are designed for integration into existing laboratory workflows, including PACS, IMS, and LIS systems, to facilitate automated analysis and provide results for pathologist review.
- Notable capabilities: The platform features an APP Center with over 130 modular image analysis units, including pretrained “Quickstart APPs” that can be customized. It supports deep learning-based classification and offers tools for tissue detection, regional segmentation, and cellular compartment definition. Visiopharm’s solutions have been featured in over 3,500 scientific publications.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-Powered Image Analysis
- Automated Tissue Detection
- Quantitative Analysis
- Continuous Learning
- Comprehensive Data Management
- Seamless System Integration
- Pretrained Quickstart APPs
- Deep Learning for custom APP training
- Spatial Biology Analysis (Phenoplexu2122)
- IHC Staining Consistency Measurement (Qualitopix)
Use Cases
- Biomarker assessment in breast cancer, lung cancer, and prostate cancer
- Metastasis detection in H&E stained lymph nodes for breast and colorectal adenocarcinoma
- Spatial biology research and analysis
- Drug discovery and development
- Clinical research and diagnostics
- IHC staining consistency measurement and documentation
What Physicians Need to Know
Leverage the IVDR certified CE-IVD APPs for standardized and automated biomarker assessment in breast, lung, and prostate cancer to enhance diagnostic accuracy and efficiency. Explore the APP Center's extensive library and Quickstart APPs to rapidly develop and refine image analysis workflows tailored to specific research or diagnostic needs. Utilize Qualitopix to ensure consistent and reliable IHC staining intensity, critical for accurate diagnostic interpretation.
The platform offers full integration with various IMS/LIMS and PACS-IMS systems, enabling a streamlined and automated workflow from image acquisition to result review, minimizing manual intervention.
Details
| Category | Oncology AI, Pathology AI |
| Pricing | Unknown |
| Deployment | On-premise, Cloud-based (via partners) |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Unknown |
| Integrations | |
| EHR | Not specified |
| Specialties | Laboratory Medicine, Oncology, Pathology |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Visiopharm AI-driven Precision Pathology
Videos
Product demos, reviews, and walkthroughs for Visiopharm AI-driven Precision Pathology.
Meet Visiopharm Customers: Prof. David Berman | Queenu2019s University in Kingston
Visiopharm





